A Case of Hypogonadotropic Hypogonadism Caused by Opioid Treatment for Nonmalignant Chronic Pain

被引：1

作者：

Tabuchi, Yukiko ^{[1
]}

Yasuda, Tetsuyuki ^{[1
]}

Kaneto, Hideaki ^{[1
]}

Kitamura, Tetsuhiro ^{[1
]}

Kozawa, Junji ^{[1
]}

Otsuki, Michio ^{[1
]}

Imagawa, Akihisa ^{[1
]}

Nakae, Aya ^{[2
]}

Matsuda, Youichi ^{[2
]}

Uematsu, Hironobu ^{[3
]}

Mashimo, Takashi ^{[2
]}

Shibata, Masahiko ^{[4
]}

Shimomura, Iichiro ^{[1
]}

机构：

[1] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan

[2] Osaka Univ, Grad Sch Med, Anesthesiol & Intens Care, Suita, Osaka 5650871, Japan

[3] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Anesthesiol, Habikino 5838588, Japan

[4] Osaka Univ, Grad Sch Med, Pain Med, Suita, Osaka 5650871, Japan

来源：

CASE REPORTS IN MEDICINE | 2012年 / 2012卷

关键词：

D O I：

10.1155/2012/740603

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report a case of 42-year-old male patient with hypogonadotropic hypogonadism. He suffered from general fatigue and erectile dysfunction after the treatment with transdermal fentanyl for chronic pain by traffic injury. Endocrine examinations and hormone stimulating tests showed that he had hypogonadotropic hypogonadism. Brain magnetic resonance imaging (MRI) showed no abnormal findings, and he had no past history of accounting for acquired hypogonadotropic hypogonadism. Therefore, his hypogonadism was diagnosed to be caused by opioid treatment. Although opioid-induced endocrine dysfunctions are not widely recognized, this case suggests that we should consider the possibility of endocrine dysfunctions in patients with opioid treatment.

引用

页数：5

共 44 条

[1] Endocrine consequences of long-term intrathecal administration of opioids
Abs, R
Verhelst, J
Maeyaert, J
Van Buyten, JP
Opsomer, F
Adriaensen, H
Verlooy, J
Van Havenbergh, T
Smet, M
Van Acker, K
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (06) : 2215 - 2222
[2] ADAMS ML, 1993, J PHARMACOL EXP THER, V266, P323
[3] FK-33-824, A MET-ENKEPHALIN ANALOG, BLOCKS CORTICOTROPIN-RELEASING HORMONE-INDUCED ADRENOCORTICOTROPIN SECRETION IN NORMAL SUBJECTS BUT NOT IN PATIENTS WITH CUSHINGS-DISEASE
ALLOLIO, B
DEUSS, U
KAULEN, D
LEONHARDT, U
KALLABIS, D
HAMEL, E
WINKELMANN, W
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (06) : 1427 - 1431
[4] Testosterone affects formalin-induced responses differently in male and female rats
Aloisi, AM
Ceccarelli, I
Fiorenzani, P
De Padova, AM
Massafra, C
[J]. NEUROSCIENCE LETTERS, 2004, 361 (1-3) : 262 - 264
[5] Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients
Aloisi, Anna Maria
Ceccarelli, Ilaria
Carlucci, Maria
Suman, Annalisa
Sindaco, Gianfranco
Mameli, Sergio
Paci, Valentina
Ravaioli, Laura
Passavanti, Giandomenico
Bachiocco, Valeria
Pari, Gilberto
[J]. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2011, 9
[6] DECREASED SERUM TESTOSTERONE CONCENTRATION IN MALE HEROIN AND METHADONE ADDICTS
AZIZI, F
VAGENAKIS, AG
LONGCOPE, C
INGBAR, SH
BRAVERMAN, LE
[J]. STEROIDS, 1973, 22 (04) : 467 - 472
[7] Sexual Dysfunction in Men Who Abuse Illicit Drugs: A Preliminary Report
Bang-Ping, Jiann
[J]. JOURNAL OF SEXUAL MEDICINE, 2009, 6 (04) : 1072 - 1080
[8] ANTAGONIST OF GONADOTROPIN-RELEASING HORMONE BLOCKS NALOXONE-INDUCED ELEVATIONS IN SERUM LUTEINIZING-HORMONE
BLANK, MS
ROBERTS, DL
[J]. NEUROENDOCRINOLOGY, 1982, 35 (05) : 309 - 312
[9] Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence
Bliesener, N
Albrecht, S
Schwager, A
Weckbecker, K
Lichtermann, D
Klingmüller, D
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) : 203 - 206
[10] Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H
Collett, B
Ventafridda, V
Cohen, R
Gallacher, D
[J]. EUROPEAN JOURNAL OF PAIN, 2006, 10 (04) : 287 - 333

← 1 2 3 4 5 →